External stakeholders
RCOphth welcomes NHS England Accessible Information Standard
By 31 July 2016 all providers of NHS and publicly funded adult social care services must have fully implemented NHS England’s Accessible Information Standard. The Royal College of Ophthalmologists welcomes this new standard to ensure that all providers offer disabled patients and carers with the most appropriate communication arrangements for their needs. Safe and effective care
SeeAbility provides framework for provision of eye care in special schools in England
SeeAbility have worked with the Association of British Dispensing Opticians, the British and Irish Orthoptic Society, the College of Optometrists, the Local Optical Committee Support Unit (LOCSU) and The Royal College of Ophthalmologists with support and advice from the Children’s Vision Service Advisory Group in Wales to provide a framework whereby all children and young people in special schools in England gain equitable
RNIB launch E-Learning resource for ophthalmologists about certifying visually impaired patients
RNIB has developed an online E-Learning resource for ophthalmologists to highlight the importance of working proactively with eligible patients to certify them as sight impaired (partially sighted) or severely sight impaired (blind) using The Certificate of Vision Impairment (CVI). The resource gives insight into the CVI process, the distinction between certification and registration, and the
British Paralympic Association searches for National Classifiers
The British Paralympic Association is looking for ophthalmologists and optometrists to train and accredit as national classifiers for athletes with a visual impairment across the Paralympic sports. Classifiers act in a voluntary capacity and are critical to the Paralympic Movement. They use their professional skills to measure each athlete’s impairment against the recognised eligibility criteria to assign an appropriate class.
Macular Society’s call for more funding of research into macular degeneration
Statement from the Macular Society Charity’s landmark report exposing lack of investment in age-related macular degeneration (AMD) is supported by more than 60 of the UK’s foremost sight researchers, ophthalmologists and institutions – Situation described as ‘urgent’ It is a disease with devastating and far-reaching consequences for both patients and their families, and the number of